Hemispherx Biopharma (HEB) Reports Q2 Loss of $0.04/Share
Tweet
Share
E-mailGet Alerts HEB Hot Sheet
Price: $1.80 --0%
Financial Fact:
Research and development: 900K
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Research and development: 900K
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Hemispherx Biopharma (NYSE: HEB) reported Q2 EPS of ($0.04), versus ($0.05) reported last year.
For earnings history and earnings-related data on Hemispherx Biopharma (HEB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
- Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
- ClearSign Technologies (CLIR) Tops Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
